These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 15817425

  • 1. Oral silymarin for chronic hepatitis C - a retrospective analysis comparing three dose regimens.
    Huber R, Futter I, Lüdtke R.
    Eur J Med Res; 2005 Feb 28; 10(2):68-70. PubMed ID: 15817425
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of diphenyl-dimethyl-dicarboxylate plus garlic oil in patients with chronic hepatitis.
    Lee MH, Kim YM, Kim SG.
    Int J Clin Pharmacol Ther; 2012 Nov 28; 50(11):778-86. PubMed ID: 22943930
    [Abstract] [Full Text] [Related]

  • 3. Non-interferon-based therapy: an option for amelioration of necro-inflammation in hepatitis C patients who cannot afford interferon therapy.
    El-Zayadi AR, Attia M, Badran HM, El-Tawil A, Zalata K, Barakat E, Selim O, El-Nakeeb A, Saied A.
    Liver Int; 2005 Aug 28; 25(4):746-51. PubMed ID: 15998425
    [Abstract] [Full Text] [Related]

  • 4. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK, Bansal SB, Gupta A, Gulati S, Kumar A, Prasad N.
    Clin Transplant; 2006 Aug 28; 20(6):677-83. PubMed ID: 17100715
    [Abstract] [Full Text] [Related]

  • 5. Artichoke leave extract for chronic hepatitis C - a pilot study.
    Huber R, Müller M, Naumann J, Schenk T, Lüdtke R.
    Phytomedicine; 2009 Sep 28; 16(9):801-4. PubMed ID: 19427774
    [Abstract] [Full Text] [Related]

  • 6. [Oral enzyme therapy for chronic hepatitis C--a retrospective analysis].
    Huber R, Futter I, Goedl R, Rostock M, Lüdtke R.
    Forsch Komplementarmed Klass Naturheilkd; 2005 Jun 28; 12(3):144-7. PubMed ID: 15985778
    [Abstract] [Full Text] [Related]

  • 7. A 24-week course of high-dose interferon-alpha plus ribavirin for Taiwanese chronic hepatitis C patients with persistently normal or near-normal alanine aminotransferase levels.
    Yu ML, Dai CY, Lee LP, Hou NJ, Hsieh MY, Huang JF, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Chuang WL.
    Liver Int; 2006 Dec 28; 26(10):1187-95. PubMed ID: 17105583
    [Abstract] [Full Text] [Related]

  • 8. [Silymarin for the treatment of acute viral hepatitis? Report of a controlled trial (author's transl)].
    Bode JC, Schmidt U, Dürr HK.
    Med Klin; 1977 Mar 25; 72(12):513-8. PubMed ID: 840125
    [Abstract] [Full Text] [Related]

  • 9. Chronic hepatitis C in patients with persistently normal alanine transaminase levels.
    Shiffman ML, Diago M, Tran A, Pockros P, Reindollar R, Prati D, Rodríguez-Torres M, Lardelli P, Blotner S, Zeuzem S.
    Clin Gastroenterol Hepatol; 2006 May 25; 4(5):645-52. PubMed ID: 16630770
    [Abstract] [Full Text] [Related]

  • 10. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study.
    Bargiggia S, Thorburn D, Anderloni A, Ardizzone S, Giorgi A, Bianchi Porro G, Parente F.
    Aliment Pharmacol Ther; 2005 Aug 01; 22(3):209-15. PubMed ID: 16091058
    [Abstract] [Full Text] [Related]

  • 11. Dietary amino acid taurine ameliorates liver injury in chronic hepatitis patients.
    Hu YH, Lin CL, Huang YW, Liu PE, Hwang DF.
    Amino Acids; 2008 Aug 01; 35(2):469-73. PubMed ID: 17690950
    [Abstract] [Full Text] [Related]

  • 12. [Inhibitory effects of silymarin on hepatic fibrosis induced by dimethylnitrosamine: experiment with rats].
    Zhao XY, Wang BE, Wang TL, Li XM.
    Zhonghua Yi Xue Za Zhi; 2006 Sep 26; 86(36):2563-6. PubMed ID: 17198567
    [Abstract] [Full Text] [Related]

  • 13. A single arm phase II study of a Far-Eastern traditional herbal formulation (sho-sai-ko-to or xiao-chai-hu-tang) in chronic hepatitis C patients.
    Deng G, Kurtz RC, Vickers A, Lau N, Yeung KS, Shia J, Cassileth B.
    J Ethnopharmacol; 2011 Jun 14; 136(1):83-7. PubMed ID: 21527335
    [Abstract] [Full Text] [Related]

  • 14. [Efficacy of combination therapy with interferon-alpha and ribavirin for chronic hepatitis C in relation to liver fibrosis and serum aminotransferase activity].
    Karpińska E, Wawrzynowicz-Syczewska M, Jurczyk K, Morańska I, Urbanowicz W, Boroń-Kaczmarska A.
    Wiad Lek; 2005 Jun 14; 58(11-12):616-21. PubMed ID: 16594470
    [Abstract] [Full Text] [Related]

  • 15. Effects of Silybum marianum on serum hepatitis C virus RNA, alanine aminotransferase levels and well-being in patients with chronic hepatitis C.
    Gordon A, Hobbs DA, Bowden DS, Bailey MJ, Mitchell J, Francis AJ, Roberts SK.
    J Gastroenterol Hepatol; 2006 Jan 14; 21(1 Pt 2):275-80. PubMed ID: 16460486
    [Abstract] [Full Text] [Related]

  • 16. Ribavirin in the treatment of hepatitis C.
    Abonyi ME, Lakatos PL.
    Anticancer Res; 2005 Jan 14; 25(2B):1315-20. PubMed ID: 15865084
    [Abstract] [Full Text] [Related]

  • 17. Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase.
    Sánchez-Conde M, Berenguer J, Miralles P, Alvarez F, Carlos Lopez J, Cosin J, Pilar C, Ramirez M, Gutierrez I, Alvarez E.
    Clin Infect Dis; 2006 Sep 01; 43(5):640-4. PubMed ID: 16886160
    [Abstract] [Full Text] [Related]

  • 18. Reduction therapy of alanine aminotransferase levels prevent HCC development in patients with HCV-associated cirrhosis.
    Rino Y, Tarao K, Morinaga S, Ohkawa S, Miyakawa K, Hirokawa S, Masaki T, Tarao N, Yukawa N, Saeki H, Takanashi Y, Imada T.
    Anticancer Res; 2006 Sep 01; 26(3B):2221-6. PubMed ID: 16821591
    [Abstract] [Full Text] [Related]

  • 19. Pilot study of interferon gamma for chronic hepatitis C.
    Soza A, Heller T, Ghany M, Lutchman G, Jake Liang T, Germain J, Hsu HH, Park Y, Hoofnagle JH.
    J Hepatol; 2005 Jul 01; 43(1):67-71. PubMed ID: 15913831
    [Abstract] [Full Text] [Related]

  • 20. Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: a randomized phase II trial.
    Orlent H, Hansen BE, Willems M, Brouwer JT, Huber R, Kullak-Ublick GA, Gerken G, Zeuzem S, Nevens F, Tielemans WC, Zondervan PE, Lagging M, Westin J, Schalm SW.
    J Hepatol; 2006 Oct 01; 45(4):539-46. PubMed ID: 16905220
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.